Clinical Trial

Scalp Care Efficacy Evaluation for Premium Revitalizing Elixir

Completed
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the efficacy of the Premium Revitalizing Elixir on human scalp skin. A total of 60 healthy adults, aged 18 to 60 with alopecia, baldness, or self-identified with symptoms of hair thinning will be recruited and randomly assigned into five groups receiving different formulations. Participants will use the product once daily for 56 days, and their scalp conditions will be assessed through skin texture tests at multiple time points. Key parameters such as sebum content, overall hair loss, hair density, scalp condition, and hair length will be measured. A self-assessment and assessment by a hair specialist on hair and scalp condition will also be provided at the end of the study (Day 56).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-27.
Status change: Active, Not Recruiting → Completed 2026-07-08
Trial Details
NCT Number NCT07271212
Lead Sponsor Hungkuang University
Collaborators: Schweitzer Biotech Company
Conditions Scalp Health, Hair Condition, Hair Loss, Alopecia, Sebum Production, Hair Health, Hair Thinning
Enrollment 60 participants
Start Date 2025-11-01
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-10